FSHR vaccine (Inovio/Wistar Institute)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFSHR vaccine (Inovio/Wistar Institute)
Drug Alias Namefollicle stimulating hormone receptor vaccine (Inovio/Wistar Institute)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncThe Wistar Institute Of Anatomy And Biology
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A